We are live on
!
Find out more
State Street SPDR S&P Pharmaceuticals ETF
XPH
XPH
66 hedge funds and large institutions have $111M invested in State Street SPDR S&P Pharmaceuticals ETF in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 19 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
21% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 19
5% more capital invested
Capital invested by funds: $105M → $111M (+$5.63M)
0.92% less ownership
Funds ownership: 54.29% → 53.38% (-0.92%)
7% less funds holding
Funds holding: 71 → 66 (-5)
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
100% less call options, than puts
Call options by funds: $2K | Put options by funds: $932K
Holders
66
Holders Change
-5
Holders Change %
-7.04%
% of All Funds
1.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
23
Reduced
19
Closed
13
Calls
$2K
Puts
$932K
Net Calls
-$930K
Net Calls Change
-$80K
Top Buyers
| 1 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$14.2M |
| 2 |
Morgan Stanley
New York
|
+$4.68M |
| 3 |
Goldman Sachs
New York
|
+$3.59M |
| 4 |
CI
CX Institutional
Auburn,
Indiana
|
+$3.36M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.36M |
Top Sellers
| 1 |
CCMG
Clark Capital Management Group
Philadelphia,
Pennsylvania
|
-$4.71M |
| 2 |
JP Morgan Chase
New York
|
-$4.45M |
| 3 |
Envestnet Asset Management
Chicago,
Illinois
|
-$4.4M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.55M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.43M |
